Table 2.
Nucleotide and amino acid mutations in the genomes of SARS-CoV-2 variants described in this study as compared to the Wuhan NC_045512.2 variant.
| Genome region | Encoded protein | Nucleotide position | Wuhan, China NC_045512.2 | Moscow, Russia EPI_ISL_428851 | Moscow, Russia EPI_ISL_428852 | ||
|---|---|---|---|---|---|---|---|
|
NT |
NT |
AA |
NT |
AA |
|||
| 5′UTR | – | 241 | C | T | N/A | T | N/A |
| ORF1ab | nsp3 (PLPro) | 3037 | C | T | Phe924 | T | Phe924 |
| 3373 | C | A | Asp1036→Glu | C | – | ||
| nsp5 (3CLPro) | 10,969 | C | C | – | T | Phe3568 | |
| nsp12 (RdRP) | 14,408 | C | T | Pro4715→Leu | T | Pro4715→Leu | |
| ORF2 | S | 23,403 | A | G | Asp614→Gly | G | Asp614→Gly |
| ORF9a | N | 28,881 | G | A | Arg203→Lys | A | Arg203→Lys |
| 28,882 | G | A | A | ||||
| 28,883 | G | C | Gly204→Arg | C | Gly204→Arg | ||
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; N/A - not applicable.